Patent · US Expired

Cardiac drug delivery system

US6358247B1 · kind B1 · utility

223Cited by
5References
60Claims
0Family size

Inventors

Key dates

Filing dateMar 2, 1999
Grant dateMar 19, 2002
Priority date
Expiry dateMar 2, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2025/0089
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A system is disclosed, for administering a therapeutic agent locally and to a depth within cardiac tissue. An elongate, flexible catheter contains a flexible electric conductor and supports at its distal end an implantable electrode incorporating a penetrating element, typically a fixation helix or a linear needle that penetrates cardiac tissue as the electrode is implanted. A therapeutic agent is delivered through the electrode, to the cardiac tissue surrounding the penetrating element. The electrode acts as a sensor, electrically coupled through the flexible conductor, and monitors an electrical condition of the surrounding cardiac tissue. A controller is coupled to the sensor and to a pump or reservoir containing the therapeutic agent, to control delivery of the agent responsive to the sensed electrical condition. The implanted electrode further can be used to deliver RF current to ablate the surrounding tissue. Several embodiments feature a distal reservoir adjacent the electrode, for effecting transient deliveries of the therapeutic agent in minute quantities or chronic delivery of growth factors. Another embodiment incorporates a bilumen catheter and a set of unidirectional v…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.